Commentary Open Access
Volume 5 | Issue 1 | DOI: https://doi.org/10.46439/anesthesia.5.025
The modern era of neuromuscular blockade: From inflammatory mechanisms to innovative neuromuscular and reversal agents
Ehab Farag1,*, Vanessa Bou Sleiman1, Maged Argalious1
- 1Department of Anesthesiology, Cleveland Clinic, Cleveland, Ohio, USA
Corresponding Author
Ehab Farag, FARAGE@ccf.org
Received Date: August 06, 2025
Accepted Date: September 09, 2025
Farag E, Sleiman VB, Argalious M. The modern era of neuromuscular blockade: From inflammatory mechanisms to innovative neuromuscular and reversal agents. J Clin Anesth Intensive Care. 2025;5(1):10-15.
Copyright: © 2025 Farag E, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Friend or foe? The elusive role of ANGPTL4 in inflammation
Angiopoietin-like 4 (ANGPTL4) is a multifaceted secreted protein discovered by three different institutions in 2000 simultaneously [1]. It is expressed in adipose tissues, liver, muscle, heart, kidney, skin, and other tissues. The nutritional, metabolic, and inflammatory status of the organism regulate the expression of ANGPTL4 [2-4].
An essential role for hepatocyte adenosine kinase in regulating fat metabolism and inflammation
Metabolic dysfunction-associated steatotic liver disease (MASLD) is comprised of a spectrum of conditions, which is a progressive form of liver disease ranging from simple steatosis to steatohepatitis. The liver regulates fat metabolic homeostasis through de novo lipogenesis, fatty acid uptake and oxidation, low-density lipoprotein secretion in hepatocytes.